Who are Phlox Therapeutics's investors?

Phlox Therapeutics's investors include ROM Utrecht Region, UvA Ventures Holding, BGV.

Where is Phlox Therapeutics headquartered?

Phlox Therapeutics is headquartered in Naarden, NL.

Phlox Therapeutics

Naarden, NL · Founded 2022 · 8 employees on LinkedIn · 11 known investors

Find your way into Phlox Therapeutics

Your email: who you already know at Phlox Therapeutics, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Phlox Therapeutics team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Phlox Therapeutics develops RNA-based precision genetic medicines and gene therapies to treat and potentially cure rare genetic heart diseases such as cardiomyopathies and laminopathies. The company targets the underlying causes of genetic cardiac dysfunction for patients underserved by current standard of care.

Biotech Healthtech

Investors · 11

ROM Utrecht Region✓ confirmed by Phlox TherapeuticsUtrecht

How we know: ROM Utrecht Region's portfolio page · the company's own site · siliconcanals.com · the VCSheet dataset · Not right? Tell us

UvA Ventures Holdinglisted by UvA Ventures HoldingAmsterdam

How we know: UvA Ventures Holding's portfolio page · Not right? Tell us

BGVreportedSilicon Valley

How we know: phloxtherapeutics.com · Not right? Tell us

Also in the syndicate · 8

AMC Ventures HoldingAmsterdam UMC Venture HoldingFIRST fundFIRST Fund (managed by BGV)Innovation Fund Noord Holland (INH)Utrecht Health Seed FundUtrecht Health Seed Fund (UHSF)Utrecht Health Seed Fund (USHF)

Funding

SEC filings, press & company announcements

Undisclosed amountseed fundingDec 2024
Amsterdam UMC Venture Holding, FIRST fund, ROM Utrecht Region, Utrecht Health Seed Fund (USHF)
Source ↗
Undisclosed amountseed financing roundMay 2023
AMC Ventures Holding, FIRST, managed by BioGeneration Ventures (BGV), Innovation Fund Noord Holland (INH), Utrecht Health Seed Fund (UHSF)
Source ↗
Undisclosed amountseed investment roundMay 2022 · 2 sources
FIRST fund, managed by BioGeneration Ventures (BGV)
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Phlox Therapeutics Raises Additional Seed Funding to Further Develop RNA Therapies for Genetic Laminopathies - Phlox Therapeuticsphloxtherapeutics.com · May 2023

Phlox Therapeutics closes seed investment round - Phlox Therapeuticsphloxtherapeutics.com · May 2022

Frequently asked questions

What does Phlox Therapeutics do?: Phlox Therapeutics develops RNA-based precision genetic medicines and gene therapies to treat and potentially cure rare genetic heart diseases such as cardiomyopathies and laminopathies. The company targets the underlying causes of genetic cardiac dysfunction for patients underserved by current standard of care.
Who are Phlox Therapeutics's investors?: Phlox Therapeutics's investors include ROM Utrecht Region, UvA Ventures Holding, BGV.
Where is Phlox Therapeutics headquartered?: Phlox Therapeutics is headquartered in Naarden, NL.